These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1285694)

  • 41. [Arteriosclerosis as the reflected image of current problems of medical science].
    Hecht A
    Zentralbl Allg Pathol; 1989; 135(6):495-500. PubMed ID: 2683495
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Regression of the plaque after prolonged pharmacologic treatment].
    Coccheri S; De Fabritiis A; Conti E
    Cardiologia; 1995 Dec; 40(12 Suppl 1):287-93. PubMed ID: 8998728
    [No Abstract]   [Full Text] [Related]  

  • 43. [Atherosclerosis: prevention of risk factors].
    Brux Med; 1977 Nov; 57(11):481. PubMed ID: 922538
    [No Abstract]   [Full Text] [Related]  

  • 44. [Regression of human arteriosclerosis].
    Lusztig G; Lesznyák J
    Zentralbl Allg Pathol; 1989; 135(6):549-52. PubMed ID: 2683502
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computerized quantitation of atherosclerosis in an experimental model. Arteriography and microdensitometry.
    Ruhn G; Erikson U; Helmius G; Hemmingsson A
    Acta Radiol Diagn (Stockh); 1982; 23(6):621-4. PubMed ID: 7171032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Editorial: Progression and regression of atherosclerosis.
    Br Med J; 1976 Feb; 1(6008):481-2. PubMed ID: 1252804
    [No Abstract]   [Full Text] [Related]  

  • 47. Problems with intervention trials in hypertension.
    Boissel JP; Moleur P
    Am Heart J; 1987 Oct; 114(4 Pt 2):1018-29. PubMed ID: 3661382
    [No Abstract]   [Full Text] [Related]  

  • 48. Prevention of atherosclerotic complications with ketanserin.
    Chalmers TC
    BMJ; 1989 Apr; 298(6679):1033. PubMed ID: 2499379
    [No Abstract]   [Full Text] [Related]  

  • 49. Ultrasound evaluation of atherosclerosis. Methodological problems and technological developments.
    Pignoli P; Longo T
    Eur Surg Res; 1986; 18(3-4):238-53. PubMed ID: 3522242
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene therapy for atherosclerotic cardiovascular disease.
    Spodick DH
    Mayo Clin Proc; 2000 Nov; 75(11):1223. PubMed ID: 11075757
    [No Abstract]   [Full Text] [Related]  

  • 51. Regression of atherosclerosis.
    Gotto AM
    Am J Med; 1981 May; 70(5):989-91. PubMed ID: 7234881
    [No Abstract]   [Full Text] [Related]  

  • 52. [New approaches to the prevention and treatment of atherosclerosis].
    Lopukhin IuM
    Kardiologiia; 1986 Oct; 26(10):5-7. PubMed ID: 3795704
    [No Abstract]   [Full Text] [Related]  

  • 53. [Translating Early Vascular Aging into Clinical Practice].
    Middeke M
    Dtsch Med Wochenschr; 2019 Mar; 144(5):329-333. PubMed ID: 30836404
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diet and atherosclerosis.
    Yudkin J
    Lancet; 1970 Mar; 1(7648):676-7. PubMed ID: 4190654
    [No Abstract]   [Full Text] [Related]  

  • 55. [Atherosclerosis].
    Fejfar Z
    Zdrav Aktual; 1983; 204():29-35. PubMed ID: 6401066
    [No Abstract]   [Full Text] [Related]  

  • 56. Problem of imbalance in risk factors in clinical trials: logistic regression is the answer.
    Singh P
    Gastroenterology; 2003 May; 124(5):1561-2. PubMed ID: 12760399
    [No Abstract]   [Full Text] [Related]  

  • 57. [Methodological problems of prevention/regression trials of atherosclerosis].
    Sassano P; Benghozi R
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():139-41. PubMed ID: 1285694
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Is regression of atherosclerosis possible?].
    Thomas D; Richard JL; Emmerich J; Bruckert E; Delahaye F
    Arch Mal Coeur Vaiss; 1992 Oct; 85 Spec No 3():47-57. PubMed ID: 1296545
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Animal models and the study of atherosclerosis.
    Vesselinovitch D
    Arch Pathol Lab Med; 1988 Oct; 112(10):1011-7. PubMed ID: 3052351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The selective peroxisomal proliferator-activated receptor-gamma agonist has an additive effect on plaque regression in combination with simvastatin in experimental atherosclerosis: in vivo study by high-resolution magnetic resonance imaging.
    Corti R; Osende JI; Fallon JT; Fuster V; Mizsei G; Jneid H; Wright SD; Chaplin WF; Badimon JJ
    J Am Coll Cardiol; 2004 Feb; 43(3):464-73. PubMed ID: 15013132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.